CDC and FDA Recommend Pause <br />of Johnson & Johnson Vaccine, Due to Rare Cases of Blood Clots.<br />Six cases of "rare and severe" blood clots have <br />been reported by people who have received <br />the Johnson & Johnson COVID vaccine.<br />Roughly 6.8 million people <br />have received that version <br />of the vaccine in the U.S.<br />A joint statement was released by both the <br />Centers for Disease Control (CDC) and the <br />Food and Drug Administration (FDA).<br />It revealed that all the reported cases of blood clots <br />occurred in women between the ages of 18 and 48.<br />and that the instances of clotting emerged between <br />six and 13 days after they received the vaccine.<br />CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance, Joint Statement of CDC and FDA, via CNN.<br />FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance <br />of caution, Joint Statement of CDC and FDA, via CNN.<br />The statement reiterated <br />that the cases are "extremely rare", <br />as rare as one case per million doses administered.<br />However, it states that anyone experiencing leg pain, <br />severe headache, shortness of breath or abdominal pain <br />within three weeks of receiving the vaccine <br />should contact their doctor immediately
